SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/A3F0F0A7B03FDC8561CB4652CBB1A5A376CB0CA99BBF11EBCAAD875BFD8F263568BC65C6A6F214640C9F68CCE032DD3C>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/A3F0F0A7B03FDC8561CB4652CBB1A5A376CB0CA99BBF11EBCAAD875BFD8F263568BC65C6A6F214640C9F68CCE032DD3C
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/A3F0F0A7B03FDC8561CB4652CBB1A5A376CB0CA99BBF11EBCAAD875BFD8F263568BC65C6A6F214640C9F68CCE032DD3C
http://www.w3.org/2000/01/rdf-schema#comment
"The anti-fibrotic effect of pirfenidone may be mediated through direct inhibition of collagen type I expression and inhibition of HSP47 expression in lung fibroblasts."
xsd:string
http://purl.uniprot.org/uniprot/#_798E2BA288E916B58E3B5EEE5F2C92C0E627CF65BE16AFE64662990FA02E0970129C28428BBCFA42613E67D98BA21CF2
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/A3F0F0A7B03FDC8561CB4652CBB1A5A376CB0CA99BBF11EBCAAD875BFD8F263568BC65C6A6F214640C9F68CCE032DD3C
http://purl.uniprot.org/uniprot/Q9NPA9
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/A3F0F0A7B03FDC8561CB4652CBB1A5A376CB0CA99BBF11EBCAAD875BFD8F263568BC65C6A6F214640C9F68CCE032DD3C
http://purl.uniprot.org/uniprot/#_Q9NPA9-mappedCitation-18093617
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/A3F0F0A7B03FDC8561CB4652CBB1A5A376CB0CA99BBF11EBCAAD875BFD8F263568BC65C6A6F214640C9F68CCE032DD3C